Logo image of MODV

MODIVCARE INC (MODV) Stock Fundamental Analysis

USA - NASDAQ:MODV - US60783X1046 - Common Stock

0.4319 USD
-0.15 (-25.23%)
Last: 8/27/2025, 8:05:27 PM
0.4569 USD
+0.02 (+5.79%)
After Hours: 8/27/2025, 8:05:27 PM
Fundamental Rating

1

Taking everything into account, MODV scores 1 out of 10 in our fundamental rating. MODV was compared to 101 industry peers in the Health Care Providers & Services industry. MODV may be in some trouble as it scores bad on both profitability and health. MODV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MODV had negative earnings in the past year.
In the past year MODV has reported a negative cash flow from operations.
MODV had negative earnings in 4 of the past 5 years.
In multiple years MODV reported negative operating cash flow during the last 5 years.
MODV Yearly Net Income VS EBIT VS OCF VS FCFMODV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

MODV's Return On Assets of -13.68% is on the low side compared to the rest of the industry. MODV is outperformed by 78.43% of its industry peers.
MODV has a Return On Invested Capital of 0.67%. This is comparable to the rest of the industry: MODV outperforms 40.20% of its industry peers.
MODV had an Average Return On Invested Capital over the past 3 years of 1.96%. This is significantly below the industry average of 9.19%.
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROIC 0.67%
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
MODV Yearly ROA, ROE, ROICMODV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

MODV's Operating Margin of 0.42% is in line compared to the rest of the industry. MODV outperforms 40.20% of its industry peers.
In the last couple of years the Operating Margin of MODV has declined.
With a Gross Margin value of 15.15%, MODV is not doing good in the industry: 63.73% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MODV has grown nicely.
Industry RankSector Rank
OM 0.42%
PM (TTM) N/A
GM 15.15%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
MODV Yearly Profit, Operating, Gross MarginsMODV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MODV is destroying value.
The number of shares outstanding for MODV has been increased compared to 1 year ago.
Compared to 5 years ago, MODV has more shares outstanding
Compared to 1 year ago, MODV has a worse debt to assets ratio.
MODV Yearly Shares OutstandingMODV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MODV Yearly Total Debt VS Total AssetsMODV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that MODV is in the distress zone and has some risk of bankruptcy.
MODV's Altman-Z score of 1.34 is on the low side compared to the rest of the industry. MODV is outperformed by 63.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.13
WACC5.2%
MODV Yearly LT Debt VS Equity VS FCFMODV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.80 indicates that MODV may have some problems paying its short term obligations.
MODV's Current ratio of 0.80 is on the low side compared to the rest of the industry. MODV is outperformed by 83.33% of its industry peers.
MODV has a Quick Ratio of 0.80. This is a bad value and indicates that MODV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MODV (0.80) is worse than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
MODV Yearly Current Assets VS Current LiabilitesMODV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The earnings per share for MODV have decreased strongly by -126.76% in the last year.
MODV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.09% yearly.
MODV shows a decrease in Revenue. In the last year, the revenue decreased by -0.70%.
Measured over the past years, MODV shows a quite strong growth in Revenue. The Revenue has been growing by 13.05% on average per year.
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%

3.2 Future

MODV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.50% yearly.
The Revenue is expected to grow by 0.26% on average over the next years.
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MODV Yearly Revenue VS EstimatesMODV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
MODV Yearly EPS VS EstimatesMODV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MODV. In the last year negative earnings were reported.
Also next year MODV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MODV Price Earnings VS Forward Price EarningsMODV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MODV is valued cheaper than 81.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.73
MODV Per share dataMODV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as MODV's earnings are expected to grow with 19.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-100.18%
EPS Next 3Y19.5%

0

5. Dividend

5.1 Amount

MODV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MODIVCARE INC

NASDAQ:MODV (8/27/2025, 8:05:27 PM)

After market: 0.4569 +0.02 (+5.79%)

0.4319

-0.15 (-25.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners97.01%
Inst Owner Change-32.92%
Ins Owners0.87%
Ins Owner Change-0.02%
Market Cap6.20M
Analysts43.33
Price Target2.01 (365.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-114.73%
Min EPS beat(2)-235.29%
Max EPS beat(2)5.84%
EPS beat(4)1
Avg EPS beat(4)-94.09%
Min EPS beat(4)-235.29%
Max EPS beat(4)5.84%
EPS beat(8)2
Avg EPS beat(8)-63.41%
EPS beat(12)4
Avg EPS beat(12)-37.21%
EPS beat(16)8
Avg EPS beat(16)-21.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-1.23%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-3.73%
Max Revenue beat(4)-1.23%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.97%
Revenue beat(16)7
Avg Revenue beat(16)0.31%
PT rev (1m)0%
PT rev (3m)-66.74%
EPS NQ rev (1m)41.67%
EPS NQ rev (3m)-887.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.47%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.73
EPS(TTM)-1.1
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-8.49
FCFYN/A
OCF(TTM)-6.83
OCFYN/A
SpS191.9
BVpS-6.11
TBVpS-72.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROCE 1.14%
ROIC 0.67%
ROICexc 0.73%
ROICexgc 3.11%
OM 0.42%
PM (TTM) N/A
GM 15.15%
FCFM N/A
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
ROICexc(3y)2.01%
ROICexc(5y)4.28%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.56%
ROCE(5y)4.87%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-39.44%
ROICexc growth 5Y-26.6%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
F-Score3
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.6
Cap/Depr 22.51%
Cap/Sales 0.87%
Interest Coverage 0.11
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 1.34
F-Score3
WACC5.2%
ROIC/WACC0.13
Cap/Depr(3y)32.88%
Cap/Depr(5y)36.51%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A
EBIT growth 1Y-59.03%
EBIT growth 3Y-46.99%
EBIT growth 5Y-12.71%
EBIT Next Year217.45%
EBIT Next 3Y52.19%
EBIT Next 5YN/A
FCF growth 1Y0.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.91%
OCF growth 3YN/A
OCF growth 5YN/A